Journal article · 2022 · Open access
Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients
Current Medical Science, 42(2), 426–433 · Published 21 March 2022 · DOI 10.1007/s11596-022-2544-1
In brief
“Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients” is a 2022 journal article by Renwang Chen and 6 co-authors, published in Current Medical Science. OpenAlex counts 9 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Research Square.
- Citations
- 9
- Most cited in
- 2024 (5)
- Field-weighted impact
- 0.81
- References
- 37
- Authors
- 7
Abstract
Purpose To validate and use the Chinese Version of the M. D. Anderson Symptom Inventory (MDASI-C) to assess the symptom burden of breast cancer patients of China. And to reveal the features of the symptoms and provide a basis for improving their quality of life.Methods A total of 342 breast cancer patients participated in the study. All patients had pathological diagnosis. They were investigated and evaluated from November 2020 to February 2021 with MDASI-C. The reliability and validity were evaluated respectively. Cluster analysis and correlation analysis were carried out.Results The Cronbach’s alpha coefficient of the symptom and interference items was 0.827 and 0.880, respectively, which meant good reliability. Construct validity revealed a four-factor structure. The Kaiser- Meyer-Olkin (KMO) value was 0.760, which meant good construct validity. The patient's KPS, treatment phase and cancer stage were grouped, and the differences of scores within the groups were significant. The patient's employment status, education level and age had a significant correlation with symptoms. The top three symptoms were disturbed sleep (3.10 ± 2.52), diffificulty remembering (2.54 ± 2.30) and fatigue (2.24 ± 2.13). The higher the patient's education, the lower their symptoms. Patients' Body Mass Index (BMI), hemoglobin (Hb), alkaline phosphatase (ALP), neutral granulocyte lymphocyte ratio (N/L), and serum albumin globulin ratio (A/G) also had an effect on some of the symptoms of patients. Conclusions MDASI-C is a reliable and effective assessment tool when evaluating patients with breast cancer of China. The symptoms were related to many clinical, biochemical indicators.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Chen, R., Wang, Q., Hu, T., Wang, J., Xie, Y., Cheng, J., & Cheng, J. (2022). Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients. Current Medical Science, 42(2), 426–433. https://doi.org/10.1007/s11596-022-2544-1
MLA 9
Chen, Renwang, et al. “Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients.” Current Medical Science, vol. 42, no. 2, 2022, pp. 426–433. https://doi.org/10.1007/s11596-022-2544-1.
Chicago
Chen, Renwang, Qiong Wang, Ting Hu, Jue Wang, Yuxiu Xie, Jing Cheng, and Jing Cheng. 2022. “Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients.” Current Medical Science 42 (2): 426–433. https://doi.org/10.1007/s11596-022-2544-1.
Harvard
Chen, R. et al. (2022) ‘Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients’, Current Medical Science, 42(2), pp. 426–433. doi:10.1007/s11596-022-2544-1.
IEEE
R. Chen et al., “Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients,” Current Medical Science, vol. 42, no. 2, pp. 426–433, 2022, doi: 10.1007/s11596-022-2544-1.
BibTeX
@article{chen2022validation,
title = {{Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients}},
author = {Chen, Renwang and Wang, Qiong and Hu, Ting and Wang, Jue and Xie, Yuxiu and Cheng, Jing and Cheng, Jing},
journal = {Current Medical Science},
year = {2022},
volume = {42},
number = {2},
pages = {426--433},
doi = {10.1007/s11596-022-2544-1},
url = {https://doi.org/10.1007/s11596-022-2544-1}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 5 | |
| 2025 | 3 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.81: it has been cited 0.81 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer survivorship and care
- MD Anderson Symptom Inventory
- Chinese version
- breast cancer
- symptom burden
- quality of life
- Chinese patients
- sleep disorders
- fatigue
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Chen, R., Wang, Q., Hu, T., Wang, J., Xie, Y., Cheng, J., & Cheng, J. (2022). Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients. Current Medical Science, 42(2), 426–433. https://doi.org/10.1007/s11596-022-2544-1
How many times has this paper been cited?
9 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Research Square: sign in and open the PDF from this page.
Who wrote this paper?
Renwang Chen, Qiong Wang, Ting Hu, Jue Wang, Yuxiu Xie, Jing Cheng, Jing Cheng.
What is the DOI of this paper?
10.1007/s11596-022-2544-1, permanently at https://doi.org/10.1007/s11596-022-2544-1. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.